Conway Medical Center announced today availability of a breakthrough outpatient procedure for the treatment of Benign Prostatic Hyperplasia (BPH), a non-cancerous enlargement of the prostate. GreenLight PVP™, or Photoselective Vaporization of the Prostate, is unlike any other enlarged prostate treatment because it combines the effectiveness of an invasive surgical procedure with the safety and ease of a minimally invasive treatment and is delivered in a single, low risk procedure. The GreenLight PVP Laser Procedure has been proven safe, effective and durable in clinical studies conducted over a five-year period at many leading medical institutions.

Choosing a BPH treatment involves careful consideration to determine if the treatment is safe, effective in relieving symptoms and restoring urine flow, long-lasting and easy to tolerate. The most commonly available treatments all require the patient to make significant compromises in these areas. Drug therapy provides some symptom relieve but requires a daily commitment to medication, is costly and will likely fail over time. Invasive surgery has been proven to be an effective treatment for BPH, but is associated with higher risks and complications, such as impotence, incontinence and blood transfusion, as well as a prolonged catheterization and a 4-6 week recovery. In contrast, most minimally invasive heat treatments offer reduced risks but also offer compromised outcomes and delayed symptom relief for several weeks following treatment.

With the GreenLight PVP Laser Procedure, BPH patients no longer need to compromise the effectiveness or the safety of treatment. The GreenLight PVP Laser Procedure is a true treatment solution, not just a step in the management of BPH.